Skip to content

Insider · CIK 0001856587

Kristen Ambrose

officer

Files at VRTX (VERTEX PHARMACEUTICALS INC / MA). First filing Feb 12, 2025, latest Feb 26, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $1.4M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

VRTX: VERTEX PHARMACEUTICALS INC / MA

VRTXOct 9, 2026 · close 510.08

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
27Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
$425k
884 shares
-9%+21% from low-7% from high
24Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
$305k
671 shares
-6%+17% from low-11% from high
35Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
$633k
1,376 shares
-12%+15% from low-12% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 28, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
AGrant or award
Common Stock
+5,000$0.00$011,62441 d ago
Feb 26, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
FTax withholding
Common Stock
-1,241$479.61$595k7,845Feb 28, 2025
Feb 24, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
FTax withholding
Common Stock10b5-1
-828$483.28$400k9,970Feb 26, 2025
Feb 25, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-884$480.95$425k9,086Feb 26, 2025
Feb 14, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
FTax withholding
Common Stock10b5-1
-564$463.46$261k11,469Feb 19, 2025
Feb 18, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-671$455.06$305k10,798Feb 19, 2025
Feb 12, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
AGrant or award
Common Stock
+2,080$0.00$012,033Feb 14, 2025
Feb 10, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
FTax withholding
Common Stock10b5-1
-591$467.98$277k11,329Feb 12, 2025
Feb 11, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SOpen-market sale
Common Stock10b5-1
-1,376$459.83$633k9,953Feb 12, 2025
Feb 4, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
AGrant or award
Common Stock
+2,566$0.00$010,066Feb 6, 2025
Feb 4, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
AGrant or award
Common Stock
+1,854$0.00$011,920Feb 6, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kristen Ambrose: insider trades and track record | InsiderTell